EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

13. What are the current branded GLP-1 self-pay prices clinics should use for comparison?

Dose Diligence research deskSection 01 · Page 13 of 34Last updated 17 Nov 2026

Use presentation-specific, dose-specific manufacturer terms—not a single starting-price headline. The following are selected public reference offers retrieved for this review, not wholesale quotations, universal eligibility promises or guaranteed future prices.

Product and presentationPublished reference pricingImportant condition
Zepbound single-dose vials or single-patient-use KwikPen$299 at 2.5 mg; $399 at 5 mg; eligible Journey offer of $449 at 7.5–15 mgContinuing higher-dose offer requires refill purchase within 45 days of prior delivery/receipt. Regular listed prices are higher at those strengths. A programme month is 28 days. (zepbound.lilly.com)
Wegovy injection, 0.25–2.4 mgEligible new-patient offer of $199 for each of two introductory fills; standard offer $349Introductory offer is limited and subject to year-end terms. (novocare.com)
Wegovy HD injection, 7.2 mg$399 under the published self-pay offerDo not assume the introductory injection offer applies. (novocare.com)
Wegovy tablets$149 at 1.5 mg; $199 at 4 mg; $299 at 9 mg and 25 mgOne bottle contains 30 tablets; eligibility and programme-change conditions apply. (novocare.com)
Foundayo tabletsStarting at $149; temporary offers include $149 at 2.5 mg and $199 at 5.5 mg through December 31, 2026Obtain the complete strength-specific schedule and continuing-offer conditions. (foundayo.lilly.com)

Oral options belong in an updated access catalogue: FDA approved Foundayo in 2026, and the retrieved Wegovy prescribing information includes tablets. This is not a recommendation to switch patients or treat products as interchangeable. (fda.gov)

For year-end orders, inspect the actual operational deadlines. NovoCare’s retrieved terms distinguish prescription-writing, pharmacy-receipt and shipment dates. (novocare.com)

Explore the table row by row

A working view of the research

Zepbound single-dose vials or single-patient-use KwikPen

Published reference pricing
$299 at 2.5 mg; $399 at 5 mg; eligible Journey offer of $449 at 7.5–15 mg
Important condition
Continuing higher-dose offer requires refill purchase within 45 days of prior delivery/receipt. Regular listed prices are higher at those strengths. A programme month is 28 days. (zepbound.lilly.com)

Sources cited on this page

  1. zepbound.lilly.com · Source 1 ↗https://zepbound.lilly.com/hcp/coverage-savings
  2. novocare.com · Source 2 ↗https://www.novocare.com/patient/medicines/wegovy/savings-offer.html
  3. foundayo.lilly.com · Source 3 ↗https://foundayo.lilly.com/coverage-savings?utm_source=openai
  4. fda.gov · Source 4 ↗https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-molecular-entity-under-national-priority-voucher-program?utm_source=openai
  5. novocare.com · Source 5 ↗https://www.novocare.com/eligibility/delivery.html
Section sources →